심혈관 및 연조직 복원용 패치 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 원재료별, 지역별 및 부문별 전망(2026-2033년)

The global cardiovascular and soft tissue repair patches market size was valued at USD 5.2 billion in 2025 and is projected to grow from USD 5.6 billion in 2026 to USD 9.7 billion by 2033, at a CAGR of 8.4% from 2026 to 2033. North America dominated the global market, accounting for a revenue share of 35.0% in 2025. A substantial congenital heart disease burden continues to support demand for surgical repair materials. The WHO reported in June 2026 that congenital heart disease affects approximately 1.35 million newborns globally each year, while about 25% of affected individuals require surgical or catheter-based intervention during infancy.

The ongoing need for surgical reconstruction and tissue reinforcement drives demand for cardiovascular and soft-tissue repair patches. Cardiovascular applications include repair of congenital and acquired defects, while soft tissue applications include hernia repair and reconstruction. Material selection remains important, with collagen-based biological materials, synthetic polymers, and newer biomaterial approaches offering different combinations of strength, flexibility, biocompatibility, and tissue integration.

Product development is increasingly shifting toward patches that integrate more effectively with native tissue and provide improved durability, controlled degradation, and regenerative properties. Advances in biomaterials, surface modification, and tissue-engineering approaches are broadening the range of repair options while improving anatomical adaptability and long-term performance. This evolution is supporting differentiation across cardiovascular and soft-tissue repair applications.

Global Cardiovascular And Soft Tissue Repair Patches Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the cardiovascular and soft tissue repair patches market report based on application, raw materials, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)

Cardiac repair

• Atrial Septal Defect
• Common Atrium
• Defects of the Endocardial Cushion
• Ventricular Septal Defect
• Tetralogy of Fallot
• Right Ventricular Outflow Tract Reconstruction
• Suture Bleeding

Vascular Repair & Reconstruction

• Carotid Endarterectomy
• Anomalous Connection of the Pulmonary Veins
• Transposition of the Great Vessels
• Reconstruction of Portal and Superior Mesenteric Veins
• Others

Pericardial Repair

Dural Repair

Soft Tissue Repair

• Defects of the Abdominal Wall
• Defects of the Thoracic Wall
• Gastric Binding
• Hernias
• Raw Material Outlook (Revenue, USD Million, 2021 - 2033)

ePTFE

Biomaterial & Tissue Engineered Material

Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• Spain
• France
• Italy
• Russia

Asia Pacific

• China
• Japan
• India
• South Korea
• Singapore
• Australia

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

Table of Contents

Chapter 1 Cardiovascular And Soft Tissue Repair Patches Market: Research Methodology

• 1.1 Market Segmentation &Scope
• 1.2 Market Definition
• 1.3 Information Procurement
  • 1.3.1 Purchased database
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources & third party perspectives
  • 1.3.4 Primary research
• 1.4 Information Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Data Visualization
• 1.6 Data Validation & Publishing

Chapter 2 Cardiovascular And Soft Tissue Repair Patches Market: Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Cardiovascular and Soft Tissue Repair Patches Market: Variables, Trends & Scope

• 3.1 Cardiovascular and soft tissue repair patches Market Lineage Outlook
  • 3.1.1 Parent market outlook
  • 3.1.2 Related/ancillary market outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Pricing Analysis
• 3.4 User Perspective Analysis
  • 3.4.1 Consumer behaviour analysis
  • 3.4.2 Market influencer analysis
• 3.5 Procedure Cost Analysis/Breakdown
• 3.6 List of Key End-users
• 3.7 Technology Overview
  • 3.7.1 Technology timeline
• 3.8 Regulatory Framework
  • 3.8.1 Reimbursement framework
  • 3.8.2 Standards and compliances
• 3.9 Cardiovascular and soft tissue repair patches Market Dynamics
  • 3.9.1 Market driver analysis
  • 3.9.2 Market restraint analysis
  • 3.9.3 Industry challenges
• 3.10 Cardiovascular and Soft Tissue Repair Patches Market Analysis Tools
  • 3.10.1 Industry analysis - Porter's
    • 3.10.1.1 Supplier power
    • 3.10.1.2 Buyer power
    • 3.10.1.3 Substitution threat
    • 3.10.1.4 Threats from new entrant
    • 3.10.1.5 Competitive rivalry
  • 3.10.2 PESTEL analysis
    • 3.10.2.1 Political landscape
    • 3.10.2.2 Enviornmental landscape
    • 3.10.2.3 Social landscape
    • 3.10.2.4 Technology landscape
    • 3.10.2.5 Economic landscape
    • 3.10.2.6 Legal landscape
  • 3.10.3 Major deals & strategic alliances analysis
    • 3.10.3.1 Joint Ventures
    • 3.10.3.2 Mergers & Acquisitions
    • 3.10.3.3 Licensing & Partnership
  • 3.10.4 Market entry strategies

Chapter 4 Cardiovascular and Soft Tissue Repair Patches Market- Competitive Analysis

• 4.1 Recent Developments & Impact Analysis, by Key Market Participants
• 4.2 Company/Competition Categorization
• 4.3 Vendor Landscape
  • 4.3.1 List of key distributors and channel partners
• 4.4 Public Companies
  • 4.4.1 Company market position analysis
  • 4.4.2 Companyranking, by region
• 4.5 Private Companies
  • 4.5.1 List of key emerging companies /technology disruptors/innovators
  • 4.5.2 Regional network map
  • 4.5.3 Company market position analysis

Chapter 5 Cardiovascular and soft Tissue Repair Patches Market: ApplicationEstimates & Trend Analysis

• 5.1 Definition & Scope
• 5.2 Application Market Share Analysis, 2021&2030
• 5.3 Segment Dashboard
• 5.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • 5.4.1 Cardiac repair
    • 5.4.1.1 Market revenue estimates and forecasts for cardiac repair, 2021 - 2033 (USD Million)
    • 5.4.1.2 Atrial septal defect
      • 5.4.1.2.1 Market revenue estimates and forecasts for atrial septal defect, 2021 - 2033 (USD Million)
    • 5.4.1.3 Common atrium
      • 5.4.1.3.1 Market revenue estimates and forecasts for common atrium, 2021 - 2033 (USD Million)
    • 5.4.1.4 Defects of the endocardial cushion
      • 5.4.1.4.1 Market revenue estimates and forecasts for defects of the endocardial cushion, 2021 - 2033 (USD Million)
    • 5.4.1.5 Ventricular septal defect
      • 5.4.1.5.1 Market revenue estimates and forecasts for ventricular septal defect, 2021 - 2033 (USD Million)
    • 5.4.1.6 Tetralogy of Fallot
      • 5.4.1.6.1 Market revenue estimates and forecaststetralogy of Fallot, 2021 - 2033 (USD Million)
    • 5.4.1.7 Right Ventricular Outflow Tract Reconstruction
      • 5.4.1.7.1 Market revenue estimates and forecasts for right ventricular outflow tract reconstruction, 2021 - 2033 (USD Million)
    • 5.4.1.8 Suturebleeding
      • 5.4.1.8.1 Market revenue estimates and forecasts for suture bleeding, 2021 - 2033 (USD Million)
    • 5.4.1.9 Market revenue estimates and forecasts for cardiac repair, by raw materials, 2021 - 2033 (USD Million)
  • 5.4.2 Vascular repair and reconstruction
    • 5.4.2.1 Market revenue estimates and forecasts for vascular repair and reconstruction, 2021 - 2033 (USD Million)
    • 5.4.2.2 Carotid endarterectomy
      • 5.4.2.2.1 Market revenue estimates and forecasts for carotid endarterectomy, 2021 - 2033 (USD Million)
    • 5.4.2.3. Anomalous connection of the pulmonary veins
      • 5.4.2.3.1 Market revenue estimates and forecasts for anomalous connection of the pulmonary veins, 2021 - 2033 (USD Million)
    • 5.4.2.4 Transposition of the great vessels
      • 5.4.2.4.1 Market revenue estimates and forecasts for transposition of the great vessels, 2021 - 2033 (USD Million)
    • 5.4.2.5 Reconstruction of portal and superior mesenteric veins
      • 5.4.2.5.1 Market revenue estimates and forecasts for reconstruction of portal and superior mesenteric veins, 2021 - 2033 (USD Million)
    • 5.4.2.6 Other vascular repair and reconstruction
      • 5.4.2.6.1 Market revenue estimates and forecasts for other vascular repair and reconstruction, 2021 - 2033 (USD Million)
    • 5.4.2.7 Market revenue estimates and forecasts for vascular repair and reconstruction, by raw materials, 2021 - 2033 (USD Million)
  • 5.4.3 Pericardial repair
    • 5.4.3.1 Market revenue estimates and forecasts for pericardial repair, 2021 - 2033 (USD Million)
    • 5.4.3.2 Market revenue estimates and forecastspericardial repair, by raw materials, 2021 - 2033 (USD Million)
  • 5.4.4 Dural repair
    • 5.4.4.1 Dural repair market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4.2 Market revenue estimates and forecasts for dural repair, by raw materials, 2021 - 2033 (USD Million)
  • 5.4.5 Soft tissue repair
    • 5.4.5.1 Soft tissue repair market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5.2 Defects of abdominal wall
      • 5.4.5.2.1 Market revenue estimates and forecasts for defects of abdominal wall, 2021 - 2033 (USD Million)
    • 5.4.5.3 Defects of thoracic wall
      • 5.4.5.3.1 Market revenue estimates and forecasts for defects of abdominal wall, 2021 - 2033 (USD Million)
    • 5.4.5.4 Gastric binding
      • 5.4.5.4.1 Market revenue estimates and forecasts for gastric binding, 2021 - 2033 (USD Million)
    • 5.4.5.5 Hernias
      • 5.4.5.5.1 Market revenue estimates and forecasts for Hernias, 2021 - 2033 (USD Million)
    • 5.4.5.6 Market revenue estimates and forecasts for soft tissue repair, by raw materials, 2021 - 2033 (USD Million)

Chapter 6 Cardiovascular and Soft Tissue Repair Patches Market: Raw Materials Estimates & Trend Analysis

• 6.1 Definition & Scope
• 6.2 Raw Materials Market Share Analysis, 2021&2030
• 6.3 Segment Dashboard
• 6.4 Global Cardiovascular and soft Tissue Repair Patches Market Revenue Estimates and Forecasts, by Raw Materials, 2021 - 2033 ( USD Million)
  • 6.4.1 ePTFE
    • 6.4.1.1 ePTFE based patches market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2 Biomaterial and tissue engineered materials
    • 6.4.2.1 Biomaterial and tissue engineered material based patches market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3 Other raw materials
    • 6.4.3.1 Otherrawmaterial-based patches market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7 Cardiovascular and soft tissue repair patches Market: Regional Estimates & Trend Analysis, By Application and By Raw Materials

• 7.1 Regional Cardiovascular and Soft Tissue Repair Patches Market Snapshot (Market size, CAGR, top verticals, top trends)
• 7.2 List of Key Players, by Region
  • 7.2.1 North America
  • 7.2.2 Europe
  • 7.2.3 Asia Pacific
  • 7.2.4 Latin America
  • 7.2.5 MEA
• 7.3 North America
  • 7.3.1 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
  • 7.3.2 North America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.3.3.U.S.
    • 7.3.3.1 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.3.3.2 U.S. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.3.4 Canada
    • 7.3.4.1 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.3.4.2 Canada cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
• 7.4 Europe
  • 7.4.1 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
  • 7.4.2 Europe cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.3. U.K.
    • 7.4.3.1 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.3.2 U.K. cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.4 Germany
    • 7.4.4.1 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.4.2 Germany cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.5. France
    • 7.4.5.1 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.5.2 France cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.6 Spain
    • 7.4.6.1 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.6.2 Spain cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.7.Italy
    • 7.4.7.1 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.7.2 Italy cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.4.8 Russia
    • 7.4.8.1 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.4.8.2 Russia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
• 7.5 Asia Pacific
  • 7.5.1 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
  • 7.5.2 Asia Pacific cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.3.2 Japan cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.4 China
    • 7.5.4.1 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.4.2 China cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.5. India
    • 7.5.5.1 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.5.2 India cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.6 Australia
    • 7.5.6.1 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.6.2 Australia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.7. Singapore
    • 7.5.7.1 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.7.2 Singapore cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.5.8 South Korea
    • 7.5.8.1 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.5.8.2 South Korea cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
• 7.6 Latin America
  • 7.6.1 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
  • 7.6.2 Latin America cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.6.3. Brazil
    • 7.6.3.1 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.6.3.2 Brazil cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.6.4 Mexico
    • 7.6.4.1 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.6.4.2 Mexico cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.6.5. Argentina
    • 7.6.5.1 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.6.5.2 Argentina cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
• 7.7 MEA
  • 7.7.1 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
  • 7.7.2 MEA cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.7.3.2 South Africa cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.7.4 Saudi Arabia
    • 7.7.4.1 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.7.4.2 Saudi Arabia cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
  • 7.7.5. UAE
    • 7.7.5.1 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by application, 2021 - 2033 (USD Million)
    • 7.7.5.2 UAE cardiovascular and soft tissue repair patches market revenue estimates and forecasts, by raw materials, 2021 - 2033 (USD Million)
• 7.8 SWOT Analysis, by Factor
  • 7.8.1 North America
  • 7.8.2 Europe
  • 7.8.3 Asia Pacific
  • 7.8.4 Latin America
  • 7.8.5 Middle East & Africa

Chapter 8 Competitive Landscape

• 8.1 Company Profiles
  • 8.1.1 Baxter
    • 8.1.1.1 Company overview
    • 8.1.1.2 Financial performance
    • 8.1.1.3 Product benchmarking
    • 8.1.1.4 Strategic initiatives
  • 8.1.2 Admedus
    • 8.1.2.1 Company overview
    • 8.1.2.2 Financial performance
    • 8.1.2.3 Product benchmarking
    • 8.1.2.4 Strategic initiatives
  • 8.1.3 Abbott (St Jude Medical)
    • 8.1.3.1 Company overview
    • 8.1.3.2 Financial performance
    • 8.1.3.3 Productbenchmarking
    • 8.1.3.4 Strategic initiatives
  • 8.1.4 LeMaitre Vascular Inc.
    • 8.1.4.1 Company overview
    • 8.1.4.2 Financial performance
    • 8.1.4.3 Product benchmarking
    • 8.1.4.4 Strategic initiatives
  • 8.1.5 Edwards Life Sciences Corporation
    • 8.1.5.1 Company overview
    • 8.1.5.2 Financial performance
    • 8.1.5.3 Productbenchmarking
    • 8.1.5.4 Strategic initiatives
  • 8.1.6 Glycar SA Pty Ltd.
    • 8.1.6.1 Company overview
    • 8.1.6.2 Financial performance
    • 8.1.6.3 Productbenchmarking
    • 8.1.6.4 Strategic initiatives
  • 8.1.7 LabCor
    • 8.1.7.1 Company overview
    • 8.1.7.2 Financial performance
    • 8.1.7.3 Product benchmarking
    • 8.1.7.4 Strategic initiatives
  • 8.1.8 Cryolife, Inc.
    • 8.1.8.1 Company overview
    • 8.1.8.2 Financial performance
    • 8.1.8.3 Product benchmarking
    • 8.1.8.4 Strategic initiatives
  • 8.1.9 CorMatrix
    • 8.1.9.1 Company overview
    • 8.1.9.2 Financial performance
    • 8.1.9.3 Product benchmarking
    • 8.1.9.4 Strategic initiatives
  • 8.1.10 Terumo Medical Corporation
    • 8.1.10.1 Company overview
    • 8.1.10.2 Financial performance
    • 8.1.10.3 Product benchmarking
    • 8.1.10.4 Strategic initiatives
  • 8.1.11 Bard Peripheral Vascular Inc.
    • 8.1.11.1 Company overview
    • 8.1.11.2 Financial performance
    • 8.1.11.3 Product benchmarking
    • 8.1.11.4 Strategic initiatives
  • 8.1.12 Neovasc
    • 8.1.12.1 Company overview
    • 8.1.12.2 Financial performance
    • 8.1.12.3 Product benchmarking
    • 8.1.12.4 Strategic initiatives
  • 8.1.13 W.L. Gore & Associates, Inc.
    • 8.1.13.1 Company overview
    • 8.1.13.2 Financial performance
    • 8.1.13.3 Product benchmarking
    • 8.1.13.4 Strategic initiatives
  • 8.1.14 B.Braun
    • 8.1.14.1 Company overview
    • 8.1.14.2 Financial performance
    • 8.1.14.3 Product benchmarking
    • 8.1.14.4 Strategic initiatives
  • 8.1.15 Novomedics
    • 8.1.15.1 Company overview
    • 8.1.15.2 Financial performance
    • 8.1.15.3 Product benchmarking
    • 8.1.15.4 Strategic initiatives
  • 8.1.16 TEI Biosciences Inc.
    • 8.1.16.1 Company overview
    • 8.1.16.2 Financial performance
    • 8.1.16.3 Product benchmarking
    • 8.1.16.4 Strategic initiatives
  • 8.1.17 Perouse Medical
    • 8.1.17.1 Company overview
    • 8.1.17.2 Financial performance
    • 8.1.17.3 Product benchmarking
    • 8.1.17.4 Strategic initiatives
  • 8.1.18 Gunze Limited
    • 8.1.18.1 Company overview
    • 8.1.18.2 Financial performance
    • 8.1.18.3 Product benchmarking
    • 8.1.18.4 Strategic initiatives
  • 8.1.19 Atriummed
    • 8.1.19.1 Company overview
    • 8.1.19.2 Financial performance
    • 8.1.19.3 Product benchmarking
    • 8.1.19.4 Strategic initiatives
  • 8.1.20 Maverick Bioscience
    • 8.1.20.1 Company overview
    • 8.1.20.2 Financial performance
    • 8.1.20.3 Product benchmarking
    • 8.1.20.4 Strategic initiatives
  • 8.1.21 Southern Lights Biomaterials
    • 8.1.21.1 Company overview
    • 8.1.21.2 Financial performance
    • 8.1.21.3 Product benchmarking
    • 8.1.21.4 Strategic initiatives
  • 8.1.22 Integra LifeSciences Corporation
    • 8.1.21.1 Company overview
    • 8.1.21.2 Financial performance
    • 8.1.21.3 Product benchmarking
    • 8.1.21.4 Strategic initiatives
• 8.2 List of Other Companies